Sitagliptin / Metformin hydrochloride Mylan União Europeia - português - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas em diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. triplo terapia de combinação), como adjuvante da dieta e exercício em pacientes inadequadamente controlados em sua máxima tolerada, a dose de metformina e uma sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Vildagliptin / Metformin hydrochloride Accord União Europeia - português - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas em diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 para dados disponíveis em diferentes combinações).

Sitagliptin / Metformin hydrochloride Sun União Europeia - português - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas em diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. triplo terapia de combinação), como adjuvante da dieta e exercício em pacientes inadequadamente controlados em sua máxima tolerada, a dose de metformina e uma sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

DIGEPLUS Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

digeplus

aché laboratórios farmacêuticos s.a - cloridrato de metoclopramida monoidratado, dimeticona, pepsina - outros digestivos

PLASIL Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

plasil

sanofi-aventis farmacÊutica ltda - cloridrato de metoclopramida monoidratado - antiemeticos e antinauseantes

PLABEL Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

plabel

belfar ltda - cloridrato de metoclopramida monoidratado - antiemeticos e antinauseantes

cloridrato de metoclopramida Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

cloridrato de metoclopramida

belfar ltda - cloridrato de metoclopramida monoidratado - antiemeticos e antinauseantes

CLORIDRATO DE METOCLOPRAMIDA Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

cloridrato de metoclopramida

cimed industria s.a - cloridrato de metoclopramida monoidratado - antiemeticos e antinauseantes

NOPROSIL Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

noprosil

halex istar indÚstria farmacÊutica sa - cloridrato de metoclopramida monoidratado - antiemeticos e antinauseantes

PLAVOM Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

plavom

cimed industria s.a - cloridrato de metoclopramida monoidratado - antiemeticos e antinauseantes